Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: LNP-formulated Lassa fever mRNA vaccines - Coalition for Epidemic Preparedness Innovations/CureVac

Next Previous
Search
Drug Profile

Research programme: LNP-formulated Lassa fever mRNA vaccines - Coalition for Epidemic Preparedness Innovations/CureVac

Alternative Names: lipid-nanoparticle-formulated Lassa fever mRNA vaccines - Coalition for Epidemic Preparedness Innovations/CureVac

Latest Information Update: 28 Jan 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator CureVac
  • Developer Coalition for Epidemic Preparedness Innovations; CureVac
  • Class RNA vaccines; Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Lassa fever

Most Recent Events

  • 28 Jan 2025 No recent reports of development identified for preclinical development in Lassa-fever(Prevention) in Germany (Parenteral)
  • 18 Dec 2020 Preclinical trials in Lassa fever (Prevention) in Germany (Parenteral) (CureVac pipeline, December 2020)
  • 27 Feb 2019 Coalition for Epidemic Preparedness Innovations and CureVac entered into a partnership agreement to develop LNP-formulated Lassa fever vaccine (Parenteral)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top